Pembrolizumab (NSCLC): Powder for injection 50 mg; Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 26 October 2018 Public Summary Document (PSD) July 2018 PBAC Meeting - (PDF 191 KB) Public Summary Document (PSD) July 2018 PBAC Meeting - (Word 77 KB)